Feil Family Brain & Mind Research Institute
Found 474 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is P  [Clear All Filters]
2016
Gupta A, Giambrone AE, Gialdini G, Finn C, Delgado D, Gutierrez J, Wright C, Beiser AS, Seshadri S, Pandya A et al..  2016.  Silent Brain Infarction and Risk of Future Stroke: A Systematic Review and Meta-Analysis.. Stroke. 47(3):719-25.
Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H.  2016.  Stroke Risk and Mortality in Patients With Ventricular Assist Devices.. Stroke. 47(11):2702-2706.
Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS.  2016.  A study of patients with aggressive multiple sclerosis at disease onset.. Neuropsychiatr Dis Treat. 12:1907-12.
Yuan P, Condello C, C Keene D, Wang Y, Bird TD, Paul SM, Luo W, Colonna M, Baddeley D, Grutzendler J.  2016.  TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy.. Neuron. 90(4):724-39.
Liu W, Zhao L, Blackman B, Parmar M, Wong MYing, Woo T, Yu F, Chiuchiolo MJ, Sondhi D, Kaminsky SM et al..  2016.  Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice.. J Neurosci. 36(49):12425-12435.
Liu W, Zhao L, Blackman B, Parmar M, Wong MYing, Woo T, Yu F, Chiuchiolo MJ, Sondhi D, Kaminsky SM et al..  2016.  Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice.. J Neurosci. 36(49):12425-12435.
2015
Sudmant PH, Rausch T, Gardner EJ, Handsaker RE, Abyzov A, Huddleston J, Zhang Y, Ye K, Jun G, Fritz MHsi-Yang et al..  2015.  An integrated map of structural variation in 2,504 human genomes.. Nature. 526(7571):75-81.
Sudmant PH, Rausch T, Gardner EJ, Handsaker RE, Abyzov A, Huddleston J, Zhang Y, Ye K, Jun G, Fritz MHsi-Yang et al..  2015.  An integrated map of structural variation in 2,504 human genomes.. Nature. 526(7571):75-81.
Vargas WS, Monohan E, Pandya S, Raj A, Vartanian T, Nguyen TD, Rúa SMHurtado, Gauthier SA.  2015.  Measuring longitudinal myelin water fraction in new multiple sclerosis lesions.. Neuroimage Clin. 9:369-75.
Luo W, Liu W, Hu X, Hanna M, Caravaca A, Paul SM.  2015.  Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody.. Sci Rep. 5:11161.
Glass MJ, Wang G, Coleman CG, Chan J, Ogorodnik E, Van Kempen TA, Milner TA, Butler SD, Young CN, Davisson RL et al..  2015.  NMDA Receptor Plasticity in the Hypothalamic Paraventricular Nucleus Contributes to the Elevated Blood Pressure Produced by Angiotensin II.. J Neurosci. 35(26):9558-67.
Jackson KL, Dayton RD, Orchard EA, Ju S, Ringe D, Petsko GA, Maquat LE, Klein RL.  2015.  Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis.. Gene Ther. 22(1):20-8.
Bennett JL, Nickerson M, Costello F, Sergott RC, Calkwood JC, Galetta SL, Balcer LJ, Markowitz CE, Vartanian T, Morrow M et al..  2015.  Re-evaluating the treatment of acute optic neuritis.. J Neurol Neurosurg Psychiatry. 86(7):799-808.
Van Kempen TA, Dodos M, Woods C, Marques-Lopes J, Justice NJ, Iadecola C, Pickel VM, Glass MJ, Milner TA.  2015.  Sex differences in NMDA GluN1 plasticity in rostral ventrolateral medulla neurons containing corticotropin-releasing factor type 1 receptor following slow-pressor angiotensin II hypertension.. Neuroscience. 307:83-97.
Hochrainer K, Pejanovic N, Olaseun VA, Zhang S, Iadecola C, Anrather J.  2015.  The ubiquitin ligase HERC3 attenuates NF-κB-dependent transcription independently of its enzymatic activity by delivering the RelA subunit for degradation.. Nucleic Acids Res. 43(20):9889-904.
2014
Garcia-Bonilla L, Park L, Iadecola C.  2014.  Commentary on Myers et al.: growing role of the innate immunity receptor CD36 in central nervous system diseases.. Exp Neurol. 261:633-7.
Mirzaa G, Parry DA, Fry AE, Giamanco KA, Schwartzentruber J, Vanstone M, Logan CV, Roberts N, Johnson CA, Singh S et al..  2014.  De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.. Nat Genet. 46(5):510-515.
Mirzaa G, Parry DA, Fry AE, Giamanco KA, Schwartzentruber J, Vanstone M, Logan CV, Roberts N, Johnson CA, Singh S et al..  2014.  De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.. Nat Genet. 46(5):510-515.
Mirzaa G, Parry DA, Fry AE, Giamanco KA, Schwartzentruber J, Vanstone M, Logan CV, Roberts N, Johnson CA, Singh S et al..  2014.  De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.. Nat Genet. 46(5):510-515.
Gilani AI, Chohan MO, Inan M, Schobel SA, Chaudhury NH, Paskewitz S, Chuhma N, Glickstein S, Merker RJ, Xu Q et al..  2014.  Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition.. Proc Natl Acad Sci U S A. 111(20):7450-5.
Park L, Wang G, Moore J, Girouard H, Zhou P, Anrather J, Iadecola C.  2014.  The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction.. Nat Commun. 5:5318.
Hu X, Li X, Zhao M, Gottesdiener A, Luo W, Paul S.  2014.  Tau pathogenesis is promoted by Aβ1-42 but not Aβ1-40.. Mol Neurodegener. 9:52.
Choi MSik, Nakamura T, Cho S-J, Han X, Holland EA, Qu J, Petsko GA, Yates JR, Liddington RC, Lipton SA.  2014.  Transnitrosylation from DJ-1 to PTEN attenuates neuronal cell death in parkinson's disease models.. J Neurosci. 34(45):15123-31.
Faraco G, Wijasa TStella, Park L, Moore J, Anrather J, Iadecola C.  2014.  Water deprivation induces neurovascular and cognitive dysfunction through vasopressin-induced oxidative stress.. J Cereb Blood Flow Metab. 34(5):852-60.